These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 21994070

  • 21. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.
    Pavese N, Metta V, Bose SK, Chaudhuri KR, Brooks DJ.
    Brain; 2010 Nov; 133(11):3434-43. PubMed ID: 20884645
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy.
    Derry C, Benjamin C, Bladin P, le Bars D, Tochon-Danguy H, Berkovic SF, Zimmer L, Costes N, Mulligan R, Reutens D.
    Neuroimage; 2006 Apr 01; 30(2):341-8. PubMed ID: 16275016
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Serotonergic Neurotransmission in Limbic Regions May Reflect Therapeutic Response of Depressive Patients: A PET Study With 11C-WAY-100635 and 18F-MPPF.
    Kitamura S, Kimura Y, Takahata K, Moriguchi S, Kubota M, Shimada H, Endo H, Takado Y, Kawamura K, Zhang MR, Suhara T, Higuchi M.
    Int J Neuropsychopharmacol; 2023 Jul 31; 26(7):474-482. PubMed ID: 37279545
    [Abstract] [Full Text] [Related]

  • 33. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.
    Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ.
    Mov Disord; 2008 Sep 15; 23(12):1776-80. PubMed ID: 18661545
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.
    Defraiteur C, Lemaire C, Luxen A, Plenevaux A.
    Nucl Med Biol; 2006 Jul 15; 33(5):667-75. PubMed ID: 16843842
    [Abstract] [Full Text] [Related]

  • 37. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.
    Baldinger P, Höflich AS, Mitterhauser M, Hahn A, Rami-Mark C, Spies M, Wadsak W, Lanzenberger R, Kasper S.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(4):. PubMed ID: 25522403
    [Abstract] [Full Text] [Related]

  • 38. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
    Jovanovic H, Lundberg J, Karlsson P, Cerin A, Saijo T, Varrone A, Halldin C, Nordström AL.
    Neuroimage; 2008 Feb 01; 39(3):1408-19. PubMed ID: 18036835
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. PET tracers for 5-HT(1A) receptors and uses thereof.
    Kumar JS, Mann JJ.
    Drug Discov Today; 2007 Sep 01; 12(17-18):748-56. PubMed ID: 17826688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.